Aarti Pharmalabs Limited has informed the Exchange about Schedule of meet on Tuesday, November 11, 2025 at 4:00 P.M. (IST) to discuss the Company's Q2-FY26 Financial Results.
AARTIPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aarti Pharmalabs has informed the exchanges that it will host an earnings conference call for investors and analysts on Tuesday, November 11, 2025, at 4:00 PM IST to discuss its Q2-FY26 financial results. The call is being organised in partnership with Emkay Global Financial Services and will feature Chairman Rashesh Gogri, Vice Chairperson and Managing Director Hetal Gogri Gala, and CFO Piyush Lakhani. The intimation has been filed under Regulation 30 of SEBI's Listing Obligations and Disclosure Requirements (LODR), 2015. Dial-in numbers have been provided for both Indian and international participants, with a pre-registration option via DiamondPass.
This is a routine disclosure ahead of the company's Q2-FY26 results and does not, by itself, impact the stock price. Investors should watch the call for management commentary on revenue growth, margins, capex updates, and any guidance for the rest of FY26, which could move the stock post-results.